Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00814359Phase 3Completed
Phase 3, randomised, open-label trial of diphenhydramine, dexamethasone, nystatin oral suspension and sucralfate in oral mucositis (OM) (2 arms), sponsored by Juravinski Hospital and Cancer Centre Foundation. Primary endpoint: Change in Oral Mucositis Weekly Questionnaire - Head and Neck Cancer Score at 6 weeks. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00814359.